Gå ubegrenset med Magzter GOLD
Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare
Prøve GULL - Gratis
BioNTech Acquires CureVac for $1.2 Billion to Boost Cancer Biz
Mint New Delhi
|June 13, 2025
BioNTech SE has agreed to buy former COVID vaccine rival CureVac NV for about $1.25 billion in an all-stock transaction to boost its growing oncology business.
CureVac investors will get around $5.46 in BioNTech shares for each CureVac one, the companies said Thursday. The price represents a 34% premium to CureVac's closing share price on Wednesday.
CureVac shareholders will own 4% to 6% of BioNTech once the transaction closes. The deal caps decades of rivalry, which came to a head during the race to develop a COVID vaccine. BioNTech had won the race with its partner Pfizer Inc., to transform into one of Europe's leading biotechs. CureVac's shot never made it to the market after proving less effective in clinical trials.
Denne historien er fra June 13, 2025-utgaven av Mint New Delhi.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint New Delhi
Mint New Delhi
EV, hydro boom to power 6x rise in battery storage by ‘47
India is preparing to meet a projected cumulative battery energy storage capacity of nearly 3 terawatt-hours (TWh) by 2047 across electric mobility, power, and electronic components, according to two people aware of the development, with electric vehicles (EVs) expected to contribute a third of the demand.
2 mins
November 27, 2025
Mint New Delhi
Taxpayer base soars, but return filings lag sharply: CBDT data
India’s income tax base is growing faster than the number of those conscientiously filing returns, driven by the expanding reach of the tax deducted at source (TDS) system, according to latest data from the central board of direct taxes (CBDT).
3 mins
November 27, 2025
Mint New Delhi
Market nears peak on dollar tailwind
Stocks jump 1.2%, but futures rollovers signal weak conviction
3 mins
November 27, 2025
Mint New Delhi
SP Eyes Tata exit to cut debt costs
Debt-laden Shapoorji Pallonji Group is banking on Tata Trusts softening the stance on its potential exit from Tata Sons to reduce its borrowing costs, two people aware of the matter said.
2 mins
November 27, 2025
Mint New Delhi
Why computers are selling like hot cakes again
Sales of laptops, desktops and tablets had a bad time in India after a pandemic boom.
2 mins
November 27, 2025
Mint New Delhi
Candidates using AI? No, thanks, say IIT recruiters
As the annual placement season dawns at the Indian Institutes of Technology (IITs), colleges and recruiters are working to bar artificial intelligence (AI) tools and prevent cheating at test venues, a concern that first rose last year.
3 mins
November 27, 2025
Mint New Delhi
Reliance JV, L&T to plough $13.5 bn into data centres
India’s data-infrastructure buildout hit a $13.5-billion inflection point on Wednesday, with a Reliance Industries Ltd (RIL) joint venture and Larsen & Toubro (L&T) announcing large-scale investments in data centres, driven by surging demand for artificial intelligence (AI) applications.
2 mins
November 27, 2025
Mint New Delhi
Softbank’s 40% fall from peak shows worry on OpenAI bet
Growing unease over frothy artificial intelligence (AI) valuations is weighing on shares of SoftBank Group Corp.
2 mins
November 27, 2025
Mint New Delhi
PepsiCo taps gourmet taste buds with Red Rock Deli’s India debut
Snack and cola maker PepsiCo is finally giving gourmet a chance with the launch of Red Rock Deli chips, priced ₹60 and ₹125 a pack, in a shift from its years-long focus on mass-market Lay's that starts as low as ₹5.
2 mins
November 27, 2025
Mint New Delhi
Fintechs turn fund magnets with cross-border licensing
Funders see growth prospects in central bank's payment aggregator-cross border licensing
3 mins
November 27, 2025
Listen
Translate
Change font size